BNP PARIBAS FINANCIAL MARKETS - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 154 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 2.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$7,238
-73.3%
54,915
+3.2%
0.00%
Q2 2023$27,145
-1.9%
53,225
+21.2%
0.00%
Q1 2023$27,666
-4.7%
43,914
-1.8%
0.00%
Q4 2022$29,016
-100.0%
44,702
-24.0%
0.00%
Q3 2022$101,217,000
+132.3%
58,847
+67.5%
0.00%
Q2 2022$43,577,000
+260.0%
35,143
+89.4%
0.00%
Q1 2022$12,106,000
-73.9%
18,556
-56.4%
0.00%
Q4 2021$46,397,000
-34.3%
42,566
+9.7%
0.00%
Q3 2021$70,598,000
+191.6%
38,790
+323.0%
0.00%
Q2 2021$24,211,000
-89.9%
9,171
-86.3%
0.00%
Q1 2021$240,714,000
+244.3%
66,865
+141.0%
0.00%
Q4 2020$69,910,000
-42.9%
27,742
-42.9%
0.00%
Q3 2020$122,414,000
+96.1%
48,577
+155.2%
0.00%
Q2 2020$62,428,000
-69.1%
19,033
-76.9%
0.00%
Q1 2020$201,936,000
+108.6%
82,423
+301.9%
0.00%
Q4 2019$96,798,000
-17.5%
20,508
-25.2%
0.00%
Q3 2019$117,268,000
+18.4%
27,399
+61.3%
0.00%
Q2 2019$99,017,000
-13.4%
16,984
-42.8%
0.00%
Q1 2019$114,322,000
+8.0%
29,694
+1274.1%
0.00%
Q4 2018$105,863,000
-45.8%
2,161
-67.4%
0.00%
Q3 2018$195,475,000
+6.4%
6,636
+4.4%
0.00%
Q2 2018$183,634,000
+66.9%
6,356
-77.4%
0.00%
Q1 2018$110,003,000
-2.8%
28,062
+2.6%
0.00%
Q4 2017$113,188,000
+35.4%
27,340
+100.8%
0.00%
Q3 2017$83,615,000
-7.4%
13,618
-6.2%
0.00%
Q2 2017$90,339,000
+855.7%
14,524
+874.1%
0.00%
Q1 2017$9,453,000
-76.9%
1,491
-80.5%
0.00%
Q4 2016$40,885,000
-21.0%
7,642
-16.9%
0.00%
Q3 2016$51,745,000
+96.1%
9,191
+91.2%
0.00%
Q2 2016$26,390,000
-88.2%
4,807
-82.1%
0.00%
-100.0%
Q4 2015$223,190,000
+4.1%
26,858
+12.9%
0.00%0.0%
Q3 2015$214,393,000
+87.2%
23,795
+149.4%
0.00%
Q2 2015$114,504,000
+398.5%
9,542
+347.4%
0.00%
Q1 2015$22,972,000
+85.6%
2,133
-54.5%
0.00%
Q3 2014$12,379,000
+3999.0%
4,689
+5482.1%
0.00%
Q1 2014$302,000
-92.1%
84
-90.5%
0.00%
Q4 2013$3,832,000
-92.7%
883
-93.4%
0.00%
Q3 2013$52,768,000
+6.0%
13,393
-43.5%
0.00%
Q2 2013$49,793,00023,7110.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders